Earlier quoted context omitted.
> All current data shows areas that have taken that approach are significantly better off today than the places that hid in a hole the past year. Source? I'd argue current data shows that those that showed an overabundance of caution, like New Zealand, are the ones significantly better off than everyone else.
New Zealand’s results are largely due to it being a small, isolated nation. Hawaii similarly enjoys the fewest COVID cases per capita of the US.
Neutralizing antibodies against SARS-CoV-2 variants after infection, vaccination
41–50 of 267 posts
Re: Neutralizing antibodies against SARS-CoV-2 variants after infection, vaccination
#42Earlier quoted context omitted.
> like New Zealand, You mean an island nation with strict control over their ports and borders?
And had mandatory lockdowns
Re: Neutralizing antibodies against SARS-CoV-2 variants after infection, vaccination
#43Earlier quoted context omitted.
> like New Zealand, You mean an island nation with strict control over their ports and borders?
And had mandatory lockdowns
Re: Neutralizing antibodies against SARS-CoV-2 variants after infection, vaccination
#44Earlier quoted context omitted.
| they are realistically at zero risk of severe illness. I didn't do it for me.
Every single person who "didn't do it for me" relied on an enormous network of people putting themselves at risk daily to keep the supply chains functioning. It's virtuization of fear and little else.
Re: Neutralizing antibodies against SARS-CoV-2 variants after infection, vaccination
#45Earlier quoted context omitted.
And had mandatory lockdowns
Mandatory lockdowns make a lot more sense when you’re an island nation that can plausibly eradicate the disease. You reasonably can expect a month of pain and then resume business as usual, but the America’s, Europe, and Asian enjoy no such hope.
Re: Neutralizing antibodies against SARS-CoV-2 variants after infection, vaccination
#46A counter point is that some vaccines seem to be ineffective agains some variants. For instance AstraZeneca against B.A.351 (South-Africa). From a preprint: "Conclusions A two-dose regimen of ChAdOx1-nCoV19 did not show protection against mild-moderate Covid-19 due to B.1.351 variant, however, VE against severe Covid-19 is undetermined." https://www.medrxiv.org/content/10.1101/2021.02.10.21251247v...
The US CDC does state that, according to current publications, some variants present a "moderate reduction on neutralization". Their page about "Variants of Interest" and "Variants of Concern" mentions many scientific papers. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/vari...
Re: Neutralizing antibodies against SARS-CoV-2 variants after infection, vaccination
#47A January 2021 study in the annals of internal medicine estimating the death rates of non institutionalized patients of .26 percent with age breakdowns . https://www.acpjournals.org/doi/10.7326/M20-5352?utm_source=...
Some more: > Indiana's IFR for noninstitutionalized persons older than 60 years is just below 2% (1 in 50). In comparison, the ratio is approximately 2.5 times greater than the estimated IFR for seasonal influenza, 0.8% (1 in 125), among those aged 65 years and older (5).
COVID-19 has a basic reproduction number of 3.3 – 5.7, while the seasonal influenza has one of 0.9 – 2.1 [1], which means that it spreads far more easily. You cannot just wait until summer for influenza season to be over.
With influenza you have a higher rate of existing immunity in the population. With COVID-19 it is basically non-existent, except maybe for a few single people that had SARS or MERS before.
Younger people are also more affected [2]
You are longer sick from COVID-19 and if you have to stay in the hospital you will stay there longer and are more likely to end up on the intensive care unit [2]
In the end you cannot compare a pandemic situation to influenza season.
[1]: https://en.wikipedia.org/wiki/Basic_reproduction_number [2]: https://www.nature.com/articles/s41598-021-85081-0
Re: Neutralizing antibodies against SARS-CoV-2 variants after infection, vaccination
#48Earlier quoted context omitted.
> All current data shows areas that have taken that approach are significantly better off today than the places that hid in a hole the past year. Source? I'd argue current data shows that those that showed an overabundance of caution, like New Zealand, are the ones significantly better off than everyone else.
New Zealand’s results are largely due to it being a small, isolated nation. Hawaii similarly enjoys the fewest COVID cases per capita of the US.
Re: Neutralizing antibodies against SARS-CoV-2 variants after infection, vaccination
#49That's basically what happened in brazil: people who were not part of risk groups crowded, encouraged by the president himself[0][1][2]. The number of infected poeple soared and variants that affect younger people appeared[3][4]. The health system has now collapsed because there is not enough ICU for such a high number of ill people[5][6].
[0] https://www.em.com.br/app/noticia/politica/2021/02/26/intern...
[1] https://noticias.uol.com.br/politica/ultimas-noticias/2021/0...
[2] https://cultura.uol.com.br/noticias/15258_bolsonaro-mergulha...
[3] https://www.cartacapital.com.br/saude/segunda-onda-de-covid-...
[4] https://www.brasildefato.com.br/2021/03/19/tres-novas-cepas-...
[5] https://www.cnnbrasil.com.br/saude/2021/03/19/17-estados-e-o...
[6] https://www.cnnbrasil.com.br/saude/2021/03/19/em-meio-ao-col...
Re: Neutralizing antibodies against SARS-CoV-2 variants after infection, vaccination
#50It seems that the AstraZeneca vaccine is not effective against the South African variant [0]. [0]: https://www.nejm.org/doi/full/10.1056/NEJMoa2102214?fbclid=I...
That's wrt mild to moderate cases. It might still be effective against severe cases.
a year later and people are still trying to twist studies into support of their favored medical treatments without actual supporting research...